NOTV

MKT CAP:$10M

Inotiv, Inc.

Market Cap

$10M

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$0.29-$0.24 (-45.51%)

Apr 22, 2026

Company Details

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates t...

CEO

Robert W. Leasure Jr.

IPO Date

Nov 25, 1997

Website

www.inotivco.com

Key Metrics TTM

Revenue

$514M

+8.2% YoY

Net Income

-$69M

EPS (Diluted)

-$2.03

Free Cash Flow

-$29M

Revenue / Share

$14.96

Gross Margin

18.1%

Operating Margin

-6.2%

Net Margin

-13.5%

FCF Margin

-5.6%

P/S

0.0x

P/E

—

Earnings Reports

Q2 2026

May 6, 2026

PENDING

Q1 2026

Feb 9, 2026

$121M+0.8%EPS -$0.83

Q4 2025

Dec 5, 2025

$138M+5.9%EPS -$0.25

Q3 2025

Aug 7, 2025

$131M+23.5%EPS -$0.51

Q2 2025

May 7, 2025

$124M+4.4%EPS -$0.44

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 21	$18M	$6M	$14.0K
Q2 21	$19M	$6M	-$521.0K
Q3 21	$23M	$8M	-$2M
Q1 22	$84M	$19M	-$34M
Q2 22	$140M	$45M	$8M
Q4 22	$150M	$42M	-$8M
Q1 23	$123M	$25M	-$91M
Q1 24	$136M	$19M	-$7M
Q2 24	$119M	$13M	-$40M
Q3 24	$106M	$21M	-$21M
Q4 24	$130M	$30M	-$13M
Q1 25	$120M	$25M	-$16M
Q2 25	$124M	$29M	-$3M
Q3 25	$131M	$34M	-$6M
Q4 25	$138M	$19M	-$7M
Q1 26	$121M	$11M	-$16M

Valuation

Quarter	P/S	P/E
Q1 21	0.1x	—
Q2 21	0.1x	—
Q3 21	0.1x	—
Q1 22	0.1x	—
Q2 22	0.0x	—
Q4 22	0.0x	—
Q1 23	0.0x	—
Q1 24	0.0x	—
Q2 24	0.0x	—
Q3 24	0.0x	—
Q4 24	0.0x	—
Q1 25	0.0x	—
Q2 25	0.0x	—
Q3 25	0.0x	—
Q4 25	0.0x	—
Q1 26	0.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 21	$2M	$178.0K
Q2 21	$3M	$2M
Q3 21	$4M	-$2M
Q1 22	-$1M	-$7M
Q2 22	$5M	-$4M
Q4 22	$171.0K	-$5M
Q1 23	-$7M	-$16M
Q1 24	-$7M	-$12M
Q2 24	$17M	$10M
Q3 24	-$15M	-$19M
Q4 24	-$2M	-$8M
Q1 25	-$4M	-$9M
Q2 25	-$13M	-$18M
Q3 25	-$7M	-$11M
Q4 25	$14M	$12M
Q1 26	-$5M	-$11M

Capital Expenditures

Quarter	CapEx
Q1 21	$1M
Q2 21	$953.0K
Q3 21	$6M
Q1 22	$6M
Q2 22	$10M
Q4 22	$5M
Q1 23	$8M
Q1 24	$6M
Q2 24	$7M
Q3 24	$4M
Q4 24	$5M
Q1 25	$4M
Q2 25	$5M
Q3 25	$4M
Q4 25	$3M
Q1 26	$5M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 21	+38.5%	+28.2%
Q2 21	+17.1%	+18.9%
Q3 21	+45.2%	+51.4%
Q1 22	+433.9%	+587.4%
Q2 22	+684.5%	+641.1%
Q4 22	+702.4%	+724.0%
Q1 23	+436.2%	+767.4%
Q1 24	+60.9%	+21.0%
Q2 24	-15.2%	+20.4%
Q3 24	-29.7%	-20.3%
Q4 24	+6.2%	-32.7%
Q1 25	-11.5%	-5.1%
Q2 25	+4.4%	-20.2%
Q3 25	+23.5%	+7.8%
Q4 25	+5.9%	+0.9%
Q1 26	+0.8%	+1.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 21	$181.0K	1.0%
Q2 21	$279.0K	1.5%
Q3 21	$580.0K	2.5%
Q1 22	$19M	22.8%
Q2 22	$1M	0.8%
Q4 22	$2M	1.3%
Q1 23	$2M	1.7%
Q1 24	$2M	1.4%
Q2 24	$2M	1.6%
Q3 24	$1M	1.3%
Q4 24	$2M	1.2%
Q1 25	$2M	1.5%
Q2 25	$1M	1.2%
Q3 25	$1M	1.1%
Q4 25	$1M	1.0%
Q1 26	$1M	1.1%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 21	$196.0K	$5M	$625.0K
Q2 21	$203.0K	$5M	$1M
Q3 21	$107.0K	$8M	$950.0K
Q1 22	—	$13M	$3M
Q2 22	—	$21M	$5M
Q4 22	—	$26M	$4M
Q1 23	—	$28M	$5M
Q1 24	—	$20M	$5M
Q2 24	—	$20M	$5M
Q3 24	—	$17M	$5M
Q4 24	—	$21M	$5M
Q1 25	—	$19M	$5M
Q2 25	—	$17M	$5M
Q3 25	—	$18M	$6M
Q4 25	—	$17M	$5M
Q1 26	—	$18M	$5M

Revenue Segments

Quarter	Product	Service
Q1 21	$853.0K	$17M
Q2 21	$849.0K	$18M
Q3 21	$968.0K	$22M
Q1 22	$46M	$38M
Q2 22	$91M	$50M
Q4 22	$95M	$55M
Q1 24	$82M	$54M
Q2 24	$62M	$57M
Q3 24	$51M	$54M
Q2 25	$68M	$56M
Q3 25	$71M	$60M
Q1 26	$61M	$60M

Revenue by Geography

Quarter	Services Segment	N	Other Than United States And Netherlands	U	Netherlands	United States
Q2 21	$18M	—	—	—	—	—
Q3 21	$22M	—	—	—	—	—
Q1 22	—	$7M	$7M	$71M	—	—
Q2 22	—	$12M	$10M	$118M	—	—
Q1 24	—	—	—	—	$18M	$112M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 21	$139M	$0	$139M
Q1 22	$42M	$0	$42M
Q4 22	$19M	$0	$19M
Q1 23	$21M	$0	$21M
Q2 23	$25M	$0	$25M
Q3 23	$22M	$0	$22M
Q4 23	$35M	$0	$35M
Q1 24	$22M	$0	$22M
Q2 24	$33M	$0	$33M
Q3 24	$14M	$0	$14M
Q4 24	$21M	$0	$21M
Q1 25	$38M	$0	$38M
Q2 25	$19M	$0	$19M
Q3 25	$6M	$0	$6M
Q4 25	$22M	$0	$22M
Q1 26	$13M	$0	$13M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 21	11M	+0.4%	+3.3%
Q2 21	11M	+1.2%	+2.8%
Q3 21	15M	+38.0%	+41.0%
Q1 22	21M	+37.3%	+92.5%
Q2 22	25M	+19.8%	+129.8%
Q4 22	26M	+1.1%	+129.5%
Q1 23	26M	+0.1%	+66.4%
Q1 24	26M	+0.6%	+22.0%
Q2 24	26M	+0.3%	+2.0%
Q3 24	26M	+0.6%	+1.6%
Q4 24	26M	+0.0%	+1.6%
Q1 25	27M	+4.5%	+5.4%
Q2 25	34M	+25.2%	+31.6%
Q3 25	34M	+1.1%	+32.2%
Q4 25	34M	+0.0%	+32.1%
Q1 26	34M	+0.0%	+26.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 21	$45.1K	397
Q2 21	$47.2K	397
Q3 21	$57.7K	397
Q1 22	$155.7K	541
Q2 22	$259.4K	541
Q4 22	$71.7K	2K
Q1 23	$58.5K	2K
Q1 24	$69.3K	2K
Q2 24	$60.9K	2K
Q3 24	$54.1K	2K
Q4 24	$66.0K	2K
Q1 25	$60.6K	2K
Q2 25	$62.9K	2K
Q3 25	$66.1K	2K
Q4 25	$71.0K	2K
Q1 26	$62.1K	2K

Revenue / Employee